Evaxion - PE Ratio 2020-2025 | EVAX

Current and historical p/e ratio for Evaxion - (EVAX) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Evaxion - PE ratio as of July 18, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Evaxion - PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-18 2.63 0.00
2025-03-31 1.85 $-21.39 0.00
2024-06-30 14.50 $-33.60 0.00
2023-06-30 65.50 $-52.50 0.00
2022-06-30 96.00 $-55.50 0.00
2022-03-31 151.50 $-63.50 0.00
2021-12-31 221.00 $-62.50 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.130B 58.69
Doximity (DOCS) United States $11.290B 52.27
Hims & Hers Health (HIMS) United States $11.277B 117.16
Tempus AI (TEM) United States $10.557B 0.00
IRhythm Technologies (IRTC) United States $4.349B 0.00
Inspire Medical Systems (INSP) United States $3.741B 58.45
Hinge Health (HNGE) United States $3.664B 0.00
Privia Health (PRVA) United States $2.391B 163.42
Schrodinger (SDGR) United States $1.574B 0.00
Phreesia (PHR) United States $1.516B 0.00
Enovis (ENOV) United States $1.502B 8.37
Clover Health Investments (CLOV) United States $1.496B 0.00
10x Genomics (TXG) United States $1.496B 0.00
Azenta (AZTA) United States $1.427B 66.30
Omnicell (OMCL) United States $1.259B 22.21
Evolent Health (EVH) United States $1.119B 95.30
Claritev (CTEV) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.541B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.467B 0.00
Butterfly Network (BFLY) United States $0.462B 0.00
Talkspace (TALK) United States $0.415B 124.00
TruBridge (TBRG) United States $0.336B 746.33
Outset Medical (OM) United States $0.309B 0.00
Nyxoah SA (NYXH) Belgium $0.280B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
CapsoVision (CV) United States $0.211B 0.00
Zepp Health (ZEPP) Netherlands $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.156B 0.00
Pulmonx (LUNG) United States $0.127B 0.00
American Well (AMWL) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.114B 0.00
CareCloud (CCLD) United States $0.101B 3.85
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.079B 0.00
111 (YI) China $0.066B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00